BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 5, Issue 3
  • This Article
Peer-Review Report of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pathophysiology
ISSN
2150-5330
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight
©2014 Baishideng Publishing Group Inc.
World J Gastrointest Pathophysiol. Aug 15, 2014; 5(3): 228-238
Published online Aug 15, 2014. doi: 10.4291/wjgp.v5.i3.228
Table 2 Treatment options for Behçet’s and Crohn’s disease
BD
CD
Extraintestinal BDIntestinal BDExtraintestinal CDIntestinal CD
ColchicineS, M, A---
CorticosteroidsAll manifestations+All manifestations+
AzathioprineS, M, O, V, N+S+
6-mercaptopurine-??-+
Cyclosporine AO---
Interferon-alphaO, N---
Mycophenolate MofetilO---
CyclophosphamideO, V, N---
MethotrexateA, N-A, S-
SulfasalazineA+A+
Mesalazine-+-+
Anti-TNF agentsA, O, N+A, S, O+
A: Arthritis; S: Skin; M: Mucosal; O: Ocular; V: Vascular; N: Neurogical Involvement; (+): Effective; (-): Non-Effective; BD: Behçet’s Disease; CD: Crohn’s disease.
Full Size Table
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.